TH112377B - The use of drone darone for the preparation of the drug for the treatment of patients with cardiac arrhythmias and creatinine increased due to the administration of drone Darone. - Google Patents
The use of drone darone for the preparation of the drug for the treatment of patients with cardiac arrhythmias and creatinine increased due to the administration of drone Darone.Info
- Publication number
- TH112377B TH112377B TH901001861A TH0901001861A TH112377B TH 112377 B TH112377 B TH 112377B TH 901001861 A TH901001861 A TH 901001861A TH 0901001861 A TH0901001861 A TH 0901001861A TH 112377 B TH112377 B TH 112377B
- Authority
- TH
- Thailand
- Prior art keywords
- darone
- drone
- patients
- treatment
- preparation
- Prior art date
Links
- 229940109239 Creatinine Drugs 0.000 title claims abstract 8
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 title claims abstract 8
- ZQTNQVWKHCQYLQ-UHFFFAOYSA-N Dronedarone Chemical compound C1=CC(OCCCN(CCCC)CCCC)=CC=C1C(=O)C1=C(CCCC)OC2=CC=C(NS(C)(=O)=O)C=C12 ZQTNQVWKHCQYLQ-UHFFFAOYSA-N 0.000 title claims abstract 6
- 229960002084 dronedarone Drugs 0.000 title claims abstract 6
- 206010007521 Cardiac arrhythmias Diseases 0.000 title claims abstract 3
- 238000002360 preparation method Methods 0.000 title claims abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drugs Drugs 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 claims abstract 2
- 239000011780 sodium chloride Substances 0.000 claims abstract 2
- 201000010099 disease Diseases 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000000977 initiatory Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Abstract
การใช้โดรนดาโรน(dronedarone)หรือเกลือที่ยอมรับทางเภสัชกรรมของมันชนิดใดชนิดหนึ่งในปริมาณซึ่งจนถึง800มก.สำหรับเตรียมเภสัชภัณฑ์สำหรับการรักษาผู้ป่วยที่มีภาวะหัวใจเสียจังหวะ,ซึ่งผู้ป่วยดังกล่าวมีการเพิ่มระดับครีเอทินินเนื่องจากการให้โดรนโรน,โดยระดับครีเอทินินดังกล่าวเพิ่มขึ้นภายหลังเริ่มการรักษาด้วยโดรนดาโรน,การเพิ่มระดับครีเอทินินดังกล่าวมาถึงระดับที่ไม่เปลี่ยนแปลงและถูกใช้เป็นเบสไลน์ใหม่,โดยการเพิ่มระดับครีเอทินินดังกล่าวสามารถผันกลับได้หลังจากหยุดให้โดรนดาโรน The use of dronedarone or any of its pharmaceutical salts up to 800 mg for the preparation of the drug for the treatment of patients with cardiac arrhythmias, of whom The levels of creatinine were increased due to the administration of drones, with increased creatinine levels after initiation of dronarone therapy, increased creatinine levels. It has reached an unchanged level and is used as a new baseline, by increasing the level of that creatinine can be reversed after stopping the Darone drone.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH112377B true TH112377B (en) | 2012-02-20 |
| TH112377A TH112377A (en) | 2012-02-20 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016034978A5 (en) | ||
| HRP20171648T1 (en) | Substituted piperidyl-ethyl-pyrimidine as ghrelin o-acyl transferase inhibitor | |
| EA201401028A1 (en) | PHARMACEUTICAL COMPOSITION, CONTAINING EMAGOGLIFLOZIN AND MEDICINES FOR OBESITY | |
| JP2013166781A5 (en) | ||
| AR086356A1 (en) | PHARMACEUTICAL COMBINATION FOR USE IN THE TREATMENT OF PATIENTS WHO HAVE TYPE 2 DIABETES | |
| JP2016510326A5 (en) | ||
| RU2015134581A (en) | NITROXIL DONORS WITH IMPROVED THERAPEUTIC INDEX | |
| JP2016520089A5 (en) | ||
| RU2020116666A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING A DEXTROMETORPHANE COMPOUND AND QUINIDINE FOR THE TREATMENT OF EXCITATION IN DEMENSE | |
| BR112017006272A2 (en) | The medicine constituent for medical treatment of chronic ulcerative colitis | |
| JP2016535780A5 (en) | ||
| AR103415A1 (en) | TREATMENT OF PEDIATRIC PATIENTS WITH MELLITUS DIABETES OF TYPE 2 | |
| JP2015516419A5 (en) | ||
| WO2016100949A3 (en) | Method and compositions for dissolving or solubilizing therapeutic agents | |
| UA100883C2 (en) | Use of dronedarone or one of its pharmaceutically acceptable salts for preparing a medicament for the treatment of patients with arrhythmia and an increased creatinine level due to dronedarone administration | |
| JP2017061488A5 (en) | ||
| CL2013000021A1 (en) | Delta crystalline form of perindopril arginine salt; preparation procedure; pharmaceutical compositions containing it; and its use for the treatment of cardiovascular diseases, such as high blood pressure, heart failure or stable coronary heart disease. | |
| CO2018009543A2 (en) | Extended release pharmaceutical composition comprising cysteamine or salt thereof | |
| HRP20171514T1 (en) | Glucopyranosyl-substituted indole-urea derivatives and their use as sglt inhibitors | |
| TH112377B (en) | The use of drone darone for the preparation of the drug for the treatment of patients with cardiac arrhythmias and creatinine increased due to the administration of drone Darone. | |
| TH112377A (en) | The use of drone darone for the preparation of the drug for the treatment of patients with cardiac arrhythmias and creatinine increased due to the administration of drone Darone. | |
| JP2016505628A5 (en) | ||
| JP2020040998A5 (en) | ||
| EA201590732A1 (en) | DISPENSABLE TABLET | |
| MX2016006375A (en) | A combination of dosage units for use in the treatment of pre-term labour condition. |